BEAM
Price
$18.08
Change
-$0.16 (-0.88%)
Updated
May 13, 01:41 PM (EDT)
Capitalization
1.83B
91 days until earnings call
PRTA
Price
$7.62
Change
+$0.01 (+0.13%)
Updated
May 13, 02:17 PM (EDT)
Capitalization
409.62M
86 days until earnings call
Ad is loading...

BEAM vs PRTA

Header iconBEAM vs PRTA Comparison
Open Charts BEAM vs PRTABanner chart's image
Beam Therapeutics
Price$18.08
Change-$0.16 (-0.88%)
Volume$300
Capitalization1.83B
Prothena
Price$7.62
Change+$0.01 (+0.13%)
Volume$120
Capitalization409.62M
BEAM vs PRTA Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. PRTA commentary
May 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and PRTA is a Hold.

Ad is loading...
COMPARISON
Comparison
May 13, 2025
Stock price -- (BEAM: $18.24 vs. PRTA: $7.61)
Brand notoriety: BEAM and PRTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 82% vs. PRTA: 152%
Market capitalization -- BEAM: $1.83B vs. PRTA: $409.62M
BEAM [@Biotechnology] is valued at $1.83B. PRTA’s [@Biotechnology] market capitalization is $409.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whilePRTA’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • PRTA’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than PRTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 6 TA indicator(s) are bullish while PRTA’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 6 bullish, 3 bearish.
  • PRTA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than PRTA.

Price Growth

BEAM (@Biotechnology) experienced а -7.97% price change this week, while PRTA (@Biotechnology) price change was -5.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.63%. For the same industry, the average monthly price growth was +10.99%, and the average quarterly price growth was -7.59%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

PRTA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+1.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.83B) has a higher market cap than PRTA($410M). BEAM YTD gains are higher at: -26.452 vs. PRTA (-45.054). PRTA has higher annual earnings (EBITDA): -153.67M vs. BEAM (-383.98M). BEAM has more cash in the bank: 851M vs. PRTA (471M). PRTA has less debt than BEAM: PRTA (10.8M) vs BEAM (161M). PRTA has higher revenues than BEAM: PRTA (135M) vs BEAM (63.5M).
BEAMPRTABEAM / PRTA
Capitalization1.83B410M447%
EBITDA-383.98M-153.67M250%
Gain YTD-26.452-45.05459%
P/E RatioN/AN/A-
Revenue63.5M135M47%
Total Cash851M471M181%
Total Debt161M10.8M1,491%
FUNDAMENTALS RATINGS
PRTA: Fundamental Ratings
PRTA
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
27

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMPRTA
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
75%
Declines
ODDS (%)
Bearish Trend 8 days ago
85%
Bearish Trend 6 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
70%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA318.3820.12
+6.75%
Tesla
AAPL210.7912.52
+6.31%
Apple
SPY582.9918.65
+3.30%
SPDR® S&P 500® ETF
GME28.050.51
+1.85%
GameStop Corp
BTC.X102812.950000-1293.406200
-1.24%
Bitcoin cryptocurrency

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+4.77%
CRSP - BEAM
72%
Closely correlated
+5.53%
NTLA - BEAM
66%
Loosely correlated
+5.30%
RXRX - BEAM
63%
Loosely correlated
+7.16%
DNLI - BEAM
60%
Loosely correlated
+2.99%
RCKT - BEAM
58%
Loosely correlated
+0.14%
More

PRTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRTA has been loosely correlated with DNLI. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PRTA jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRTA
1D Price
Change %
PRTA100%
+2.42%
DNLI - PRTA
49%
Loosely correlated
+2.99%
KRYS - PRTA
45%
Loosely correlated
+5.48%
CLDX - PRTA
40%
Loosely correlated
+10.09%
ACLX - PRTA
40%
Loosely correlated
+3.39%
BEAM - PRTA
39%
Loosely correlated
+4.77%
More